Revascularization

WASHINGTON — Complete revascularization, as opposed to culprit lesion-only revascularization, was associated with better angina-related quality of life in patients with STEMI and multivessel CAD, a speaker reported.

A novel, interdisciplinary limb salvage team reevaluating severe cases of critical limb ischemia avoided amputation for 75% of patients 180 days after revascularization, according to findings from a small study.

In patients with critical limb ischemia, CT-derived fractional flow reserve often detected silent coronary ischemia, and selective revascularization of those diagnosed with it improved outcomes, according to a presentation.

Among postmenopausal women with acute MI, Black women were less likely to receive revascularization, particularly PCI, compared with white women, researchers reported.

CVD is the leading cause of death in women globally, but women are less likely to receive CV procedures than men, and not enough is known about sex differences for those procedures, a panel concluded.

Contemporary data suggest paclitaxel-coated devices do not elevate mortality risk in patients with peripheral artery disease, and they should be used more routinely, according to a speaker.

Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates significantly declining for patients with non-STEMI and remaining stable for patients with STEMI.

In a meta-analysis of seven trials, colchicine was associated with reduced risk for MACE in patients with CAD who underwent PCI.

Coronary revascularization confers similar outcomes regardless of race, ethnicity or sex, so decisions on revascularization should be made based on clinical indications, according to a new guideline.

Among patients with left main CAD, the incidence of MACCE was similar with coronary revascularization in male and female patients, according to 10-year results of the PRECOMBAT trial.